Unable to load price data. Sorry.

¯\_(ツ)_/¯

Elan Corp, plc (ADR) (NYSE:ELN.DL)

CAPS Rating: No stars

The Company's Biopharmaceuticals unit is engaged in research, development and commercial activities and its EDT unit focuses on product development, scale-up and manufacturing to address drug optimization challenges of the pharmaceutical industry.

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NYSE:ELN.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

drdukemonty (< 20)
Submitted May 25, 2013

due to buy out talks

michjksn (< 20)
Submitted February 27, 2009

Historically poorly run company. One product which causes death all too often/terrible press. No products on horizon, including Bap, worth anything other than being money pits for underachievement. What R&D there was, has been all but killed off due… More

NYSE:ELN.DL VS S&P 500 (SPY)

NYSE:ELN.DL Summary

  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about ELN.DL.

No one has written a Pitch for ELN.DL stock yet. Tell us why you think ELN.DL will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in ELN.DL.

No players have picked ELN.DL yet. Tell us why you think ELN.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ELN.DL.